Glessner, Mary
- Ppd Development LP (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #415
- Sustained Excellence
- Top 5% Funded
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2012 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$7.3M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#415
By linked amount among FY2023 PIs
Earliest Year Loaded
2012
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Glessner, Mary as a PI. Multi-PI records show the full award amount for context.
- 75N93022C00014-P00002-9999-1N01Contact PINATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC)$7.3Maward amount
- 271201800025I-P00007-27100001-1N02Contact PIPOP: 09/28/2019-09/27/2020 CLINICAL SITE AND STUDY MONITORING FOR RESEARCH PARTNERSHIPS FOR GLOBAL MENTAL HEALTH.$25.1Kaward amount
Award organization
Organizations that administered FY2023 awards listing Glessner, Mary as a PI.
FY2023 award administered by Ppd Development LP (NC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2012First NIH AwardPpd Development LP
- 2012$500K Cumulative Funding
- 2012$1M Cumulative Funding
- 2012$2M Cumulative Funding
- 2012Entered Top 50% NationallyRanked #2509
- 2012Entered Top 25% NationallyRanked #2509
- 2014$5M Cumulative Funding
- 2016$10M Cumulative Funding
- 2016Entered Top 10% NationallyRanked #1988
- 2022$25M Cumulative Funding
- 2022$50M Cumulative Funding
- 2022Entered Top 5% NationallyRanked #21
- 2022Entered Top 1% NationallyRanked #21